Bromhexine Syrup, 4mg/5ml 100ml

Each 5ml contains Bromhexine hydrochloride 4mg.
PHARMACOLOGICAL CLASSIFICATION
Medicines that act on the respiratory system, antitussives and expectorants
PHARMACOLOGICAL ACTION
Bromhexine syrup has mucolytic and bronchodilatory properties.
INDICATIONS
Bromhexine syrup is indicated for cough associated with wheeziness (bronchospasm) and tenacious phlegm (sputum)
CONTRAINDICATIONS
Bromhexine syrup is contra-indicated in patients with hypersensitivity to known sympathomimetic amines or any of the Other ingredients; hypertrophic obstructive cardiomyopathy, and tachyarrhythmia. Sympathomimetics, such as sulphate of orciprenaline may interact with monoamine oxidase inhibitors (MAOIS), and therefore the bromhexine syrup should not be given to patients receiving such treatment or within 14 days of termination of the MAOI treatment.
Safety in pregnancy and lactation has not been established.
DOSAGE AND DIRECTIONS FOR USE
Adults and children over 12 years: 10-20ml three times daily
Children 3-12 years: 5-10ml three times daily
Children 1-3 years: 2.5-5ml three times daily
Infants: 2.5ml three time diily
Do not exceed recommended dose.
STORAGE
Store below 25ºC, In well-closed containers.
Protect from light.
KEEP ALL MEDICINES OUR OF REACH OF CHILDREN.
 
Each 5ml contains Bromhexine hydrochloride 4mg.
PHARMACOLOGICAL CLASSIFICATION
Medicines that act on the respiratory system, antitussives and expectorants
PHARMACOLOGICAL ACTION
Bromhexine syrup has mucolytic and bronchodilatory properties.
INDICATIONS
Bromhexine syrup is indicated for cough associated with wheeziness (bronchospasm) and tenacious phlegm (sputum)
CONTRAINDICATIONS
Bromhexine syrup is contra-indicated in patients with hypersensitivity to known sympathomimetic amines or any of the other ingredients; hypertrophic obstructive cardiomyopathy, and tachyarrhythmia. Sympathomimetics, such as sulphate of orciprenaline may interact with monoamine oxidase inhibitors (MAOIS), and therefore the bromhexine syrup should not be given to patients receiving such treatment or within 14 days of termination of the MAOI treatment.
Safety in pregnancy and lactation has not been established.
DOSAGE AND DIRECTIONS FOR USE
Adults and children over 12 years: 10-20ml three times daily
Children 3-12 years: 5-10ml three times daily
Children 1-3 years: 2.5-5ml three times daily
Infants: 2.5ml three time diily
Do not exceed recommended dose.
STORAGE
Store below 25ºC, In well-closed containers.
Protect from light.
KEEP ALL MEDICINES OUR OF REACH OF CHILDREN.
 

FLT3 Inhibitor

Our FLT3 Inhibitor products is good in quality and competitive in price.

We are manufacturer and supplier of FLT3 Inhibitor products following your specific requirement.

We are looking forward to your E-mail and establishing cooperative relationship with you.

We would provide professional FLT3 Inhibitor products with good services for you.

FLT3 Inhibitor

Amuvatinib Inhibitor, Cabozantinib Inhibitor, MLN518 Inhibitor, Tandutinib Inhibitor

Taizhou Crene Biotechnology Co., Ltd. , http://www.crenelab.com